Hosted on MSN1mon
Galderma’s prurigo nodularis trial of nemolizumab meets endpoints
Notably, over six times as many subjects in the therapy arm reported itch response, and more than 20 times as many reached a peak-pruritus numerical rating scale (PP-NRS) score of less than two ...
Hosted on MSN9mon
AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study
WP-NRS is an assessment tool that patients use to report the intensity of their pruritus daily (with 0 being ‘no itch’ and 10 being the ‘worst imaginable itch’). Upadacitinib also showed ...